5 Recommendations for research
5.1 The committee noted an ongoing randomised controlled trial of the effectiveness of andexanet alfa compared with standard care in people with intracranial haemorrhage. The main outcomes of interest are haemostatic efficacy and short-term mortality and neurological outcomes.